Elanco Onsior 40 mg tablets

Onsior is a prominent veterinary non-steroidal anti-inflammatory drug (NSAID) primarily used to manage pain and inflammation in dogs and cats. The specific 40 mg tablet shown in the image is formulated for canine use, containing the active ingredient robenacoxib.

While the brand is global, the manufacturing for the European market is typically centered in Huningue, France, at Elanco's specialized production facilities. This location is responsible for the batch release of the tablets across the European Union and other international markets.

The brand is owned by Elanco Animal Health Incorporated, a major American pharmaceutical company. Elanco was originally established as a division of Eli Lilly and Company in 1953 but was spun off as an independent, publicly-traded company in 2019. Today, it stands as one of the largest independent animal health companies in the world.